AACR 2024 | The current state of genomic profiling in colorectal cancer

Paolo Manca, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the current role of biomarker testing in colorectal cancer. Whilst genomic profiling has entered clinical practice, there are fewer actionable genes compared to other solid tumors. However, current genomic profiling techniques can inform clinicians of potential metastatic spread and potential follow-up treatment options. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.